| | Webinar: The Benefits of Pharmacist-Led Clinical Trials Tuesday, February 23, 2021 | 1pm ET / 10am PT This webinar will focus on how a pharmacist-led clinical trial model impacts the six key areas most relevant to clinical trials in today’s COVID and Decentralized Clinical Trial environment: regulations, recruiting, diversity, clinical outcomes, data integrity, and clinical supply chain. Register Now. |
There's a scramble to create digital 'health passports.' These companies are teaming up to make sure they all work Merck canned its own COVID-19 vaccines. Now, it's in talks to manufacture other companies' shots FDA greenlights Visby Medical's single-use, portable PCR test for COVID-19 Nearly half of rural hospitals face negative operating margins as COVID-19 hits outpatient revenue AstraZeneca's COVID-19 vaccine rollout is the headline-grabber, but new drug launches drove 2020 growth IQVIA books Q4 revenue jump as R&D solutions unit returns to growth after a tough year Biopharma roundup—Novavax nears European supply deal Docs stitched together creative responses in pandemic's first year. Now, they need more targeted support: study Cancer during COVID-19: Novartis exec Schaffert headlines campaign highlighting the other 'C' word Featured Story | By Heather Landi Companies in the technology, health and travel sectors have banded together as part of the Good Health Pass Collaborative to create a "blueprint for interoperable digital health pass systems." read more |
| |
|---|
|
Top Stories By Eric Sagonowsky After Merck got off to a late start in the COVID-19 vaccine race and made an early exit, the drug giant is in talks to produce doses for other companies. Merck is "actively involved" in discussions with governments, health agencies and vaccine makers about the ways it can help, a spokesman said. read more By Conor Hale Visby Medical received a new emergency authorization from the FDA for its rapid, single-use PCR test designed to detect COVID-19 infections at the point of care. read more By Robert King Nearly half of rural hospitals are dealing with negative operating margins as the pandemic has caused major holes to facilities' outpatient revenues, a new study said. read more By Eric Sagonowsky While AstraZeneca stands on the world stage with its COVID-19 vaccine rollout, the drugmaker’s suite of new drug launches propelled its financial performance last year, generating more than half of overall sales. read more By Ben Adams IQVIA has seen a big jump in revenue for the fourth quarter as it continues to steer around pandemic roadblocks. read more By Fraiser Kansteiner,Eric Sagonowsky,Angus Liu,Conor Hale Novavax is nearing a vaccine supply deal with Europe, while Visby Medical scored an FDA nod for its rapid PCR test. Meanwhile, drugmakers are looking at alternative ways to show their vaccines' effectiveness. read more By Tina Reed In one case, a Virginia primary care practice said an insurer offered financial help but only on the condition the practice refrain from being acquired by a hospital or larger physician group for a number of years. read more By Sharon Klahr Coey Novartis' new awareness campaign reminds people that another “C" word remains a global health problem during the pandemic. While COVID-19 dominates headlines, cancer is still hurting people every day, too. read more |
